Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New DNA method may spot hidden joint infections faster

NCT ID NCT06062251

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a new DNA-based technique called shotgun metagenomics to see if it can diagnose chronic infections in artificial joints better than standard lab cultures. Researchers took samples from 144 adults undergoing surgery for a suspected joint infection. The goal was to compare the accuracy of the DNA test against the usual diagnostic score. If successful, this method could lead to faster and more precise detection of infection-causing bacteria.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

144 people

The number who actually took part.

Started

Feb 2024

Finished

Mar 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patients with suspected chronic prosthetic joint infection

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Male or female ≥ 18 years * Patients being considered for surgery for suspected chronic PJI (time between joint replacement surgery and patient inclusion \> 3 months) * Social security affiliation * No objection to participating in the study Exclusion Criteria: * Suspicion or documentation (positive blood cultures) of acute bacteremia at time of inclusion * Patients under guardianship or trusteeship * Pregnant or breastfeeding woman * Patient deprived of liberty by legal or administrative decision * Patients in psychiatric care

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Prosthetic-joint infection are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Brest university hospital

    Brest, Brest, 29200, France

  • Dr Chloé PLOUZEAU

    Poitiers, France

  • Dr Marie-Frédérique LARTIGUE

    Tours, France

  • Dr REISSIER Sophie

    Rennes, France

  • Dr Rachel CHENOUARD

    Angers, France

  • Dr Stéphane CORVEC

    Nantes, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.